AVITA Medical (RCEL) Income from Continuing Operations (2018 - 2025)
AVITA Medical (RCEL) posted Income from Continuing Operations of 1409000.0 for Q4 2025, up 89.32% on a QoQ basis from 13187000.0 in Q3 2025, and up 87.83% year-over-year from 750153.34 in Q4 2024.
AVITA Medical (RCEL) Income from Continuing Operations (2018 - 2025) Analysis & Trends
AVITA Medical's Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 1409000.0 for Q4 2025.
- Quarterly Income from Continuing Operations rose 87.83% year-over-year to 1409000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 38375000.0 (up 37.94% YoY) and the FY2025 annual result came in at 38375000.0, up 37.94% from the prior year.
- Income from Continuing Operations was 1409000.0 for Q4 2025 at AVITA Medical, up from 13187000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 21411000.0 in Q4 2022 and bottomed at 18658000.0 in Q1 2024.
- A 5-year average of 9033500.0 and a median of 10152000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 133.0% — and 2025, when it surged 87.83%.
- AVITA Medical's Income from Continuing Operations stood at 16663000.0 in 2021, then soared by 228.49% to 21411000.0 in 2022, then plunged by 133.0% to 7065000.0 in 2023, then sank by 63.85% to 11576000.0 in 2024, then jumped by 87.83% to 1409000.0 in 2025.
- Business Quant data shows RCEL's Income from Continuing Operations at 1409000.0 in Q4 2025, 13187000.0 in Q3 2025, and 9920000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | -13.19 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -13.86 Mn |
| Dec 31, 2024 | -11.58 Mn |
| Sep 30, 2024 | -16.21 Mn |
| Jun 30, 2024 | -15.39 Mn |
| Mar 31, 2024 | -18.66 Mn |
| Dec 31, 2023 | -7.07 Mn |
| Sep 30, 2023 | -8.71 Mn |
| Jun 30, 2023 | -10.38 Mn |
| Mar 31, 2023 | -9.22 Mn |
| Dec 31, 2022 | 21.41 Mn |
| Sep 30, 2022 | -5.59 Mn |
| Mar 31, 2022 | -9.46 Mn |
| Sep 30, 2021 | -16.66 Mn |
| Jun 30, 2021 | -10.72 Mn |
| Mar 31, 2021 | -6.00 Mn |
| Dec 31, 2020 | -5.64 Mn |
| Sep 30, 2020 | -10.23 Mn |